These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 34579822)

  • 61. Meta-analysis and meta-analytic monitoring of clinical trials.
    Feinstein AR
    Stat Med; 1996 Jun; 15(12):1273-80; discussion 1281-3. PubMed ID: 8817801
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Every effect size has its place: a commentary on the avoidance of pre-post effect sizes.
    Kösters M
    Epidemiol Psychiatr Sci; 2017 Aug; 26(4):369-370. PubMed ID: 28202092
    [No Abstract]   [Full Text] [Related]  

  • 63. Systematic reviews and meta-analysis of published studies: an overview and best practices.
    Mandrekar JN; Mandrekar SJ
    J Thorac Oncol; 2011 Aug; 6(8):1301-3. PubMed ID: 21847059
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods.
    White IR; Higgins JP; Wood AM
    Stat Med; 2008 Feb; 27(5):711-27. PubMed ID: 17703496
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Meta-analysis: a method for synthesizing research.
    D'Agostino RB; Weintraub M
    Clin Pharmacol Ther; 1995 Dec; 58(6):605-16. PubMed ID: 8529325
    [No Abstract]   [Full Text] [Related]  

  • 66. Handling of rescue and missing data affects synthesis and interpretation of evidence: the sodium-glucose cotransporter 2 inhibitor example.
    Stack CB; Localio AR; Griswold ME; Goodman SN; Mulrow CD
    Ann Intern Med; 2013 Aug; 159(4):285-8. PubMed ID: 24026261
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Meta-analysis: How to quantify and explain heterogeneity?
    Ruppar T
    Eur J Cardiovasc Nurs; 2020 Oct; 19(7):646-652. PubMed ID: 32757621
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.
    Darvishian M; van den Heuvel ER; Bissielo A; Castilla J; Cohen C; Englund H; Gefenaite G; Huang WT; la Bastide-van Gemert S; Martinez-Baz I; McAnerney JM; Ntshoe GM; Suzuki M; Turner N; Hak E
    Lancet Respir Med; 2017 Mar; 5(3):200-211. PubMed ID: 28189522
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Continuous(ly) missing outcome data in network meta-analysis: A one-stage pattern-mixture model approach.
    Spineli LM; Kalyvas C; Papadimitropoulou K
    Stat Methods Med Res; 2021 Apr; 30(4):958-975. PubMed ID: 33406990
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Meta-synthesis: a research methodology].
    Carrillo-González GM; Gómez-Ramírez OJ; Vargas-Rosero E
    Rev Salud Publica (Bogota); 2007; 9(4):609-17. PubMed ID: 18209828
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Meta-analysis at middle age: a personal history.
    Glass GV
    Res Synth Methods; 2015 Sep; 6(3):221-31. PubMed ID: 26355796
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Qualitative assessment of studies included in a meta-analysis: DES and the risk of pregnancy loss.
    Macarthur C; Foran PJ; Bailar JC
    J Clin Epidemiol; 1995 Jun; 48(6):739-47. PubMed ID: 7769404
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
    Hoaglin DC; Hawkins N; Jansen JP; Scott DA; Itzler R; Cappelleri JC; Boersma C; Thompson D; Larholt KM; Diaz M; Barrett A
    Value Health; 2011 Jun; 14(4):429-37. PubMed ID: 21669367
    [TBL] [Abstract][Full Text] [Related]  

  • 74. How to critically appraise and apply meta-analyses in clinical practice.
    Ho RC; Ong HS; Kudva KG; Cheung MW; Mak A
    Int J Rheum Dis; 2010 Oct; 13(4):294-9. PubMed ID: 21199464
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Using response ratios for meta-analyzing single-case designs with behavioral outcomes.
    Pustejovsky JE
    J Sch Psychol; 2018 Jun; 68():99-112. PubMed ID: 29861034
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Detecting small-study effects and funnel plot asymmetry in meta-analysis of survival data: A comparison of new and existing tests.
    Debray TPA; Moons KGM; Riley RD
    Res Synth Methods; 2018 Mar; 9(1):41-50. PubMed ID: 28975717
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of clinically useful cancer prognostic factors: what are we missing?
    McShane LM; Altman DG; Sauerbrei W
    J Natl Cancer Inst; 2005 Jul; 97(14):1023-5. PubMed ID: 16030294
    [No Abstract]   [Full Text] [Related]  

  • 78. Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied example.
    de Jong VMT; Moons KGM; Riley RD; Tudur Smith C; Marson AG; Eijkemans MJC; Debray TPA
    Res Synth Methods; 2020 Mar; 11(2):148-168. PubMed ID: 31759339
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The case for failed meta-analyses.
    Naylor CD
    J Eval Clin Pract; 1995 Nov; 1(2):127-30. PubMed ID: 9238567
    [No Abstract]   [Full Text] [Related]  

  • 80. Handling incomplete correlated continuous and binary outcomes in meta-analysis of individual participant data.
    Gomes M; Hatfield L; Normand SL
    Stat Med; 2016 Sep; 35(21):3676-89. PubMed ID: 27090498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.